The speaker Dr. Richard Ablin discovered the PSA value in 1970 and is now reflecting critically on its use for prostate cancer screening.
Moderation: Prof. Dr. Ulrich Dirnagl Founding Director of QUEST – The Center for Transforming Biomedical Research, Berlin Institute of Health
Panel discussion:
Prof. Gerd Gigerenzer Director at the Max Planck Institute for Human Development, Director of the Harding Center for Risk Literacy in Berlin
Prof. Dr. Dr. Tobias Kurth Director of the Institute of Public Health Charité – Universitätsmedizin Berlin
Prof. Dr. med. Carsten Stephan Clinic for Urology Charité – Universitätsmedizin Berlin